2Rajalaliths P, Vali S. Molecular pathogenesis of oral submusous fibrosis-A collagen metabolic disorder. J Oral Pathol Med, 2005, 34:321-328.
3Williams K L, Fuller C R, Fagin J, et al. Mesenchymat IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions. Am J Physiol Gastrointest Liver Physiol, 2002, 283: G875-G885.
4Williams K L, Fuller C R, Fagin J, et al. Mesenchymal IGF- I overexpression., paracrine effects in the intestine, distinct from endocrine actions. Am J Physiol Gastrointest Liver Physiol, 2002, 283:G875-G885.
5Pucilowska J B, McNaughton K K, Mohapatra N K, et al. IGF-I and procollagen alpha1(Ⅰ) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointest Liver Physiol, 2000, 279: G1307- G1322.
6Kuemmerle J F, Zhou H, Bowers J G. IGF-I stimulates human intestinal smooth musele cell growth by regulation of G1 phase cell cycle proteins. Am J Physiol Gastrointest Liver Physiol, 2004, 286 : G412-G419.
7Simmons J G, Pucilowska J B, Keku T O, et al. IGF-I and TGF-betal have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol, 2002, 283: G809-G818.
8Xin X, Hou Y T, Li L, et al. IGF I increases IGFBP- 5 and collagen {alpha} 1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells. Am J Physiol Gastrointest Liver Physiol, 2004, 286:G777-G783.
9Bushman T L, Kuemmerle J F. IGFBP-3 and IGFBP- 5 production by human intestinal muscle: reciprocal regulation by endogenous TGF betal. Am J Physiol, 1998, 275: G1282- G1290.
